TUSTIN, Calif., Sept ... The shift will enable the fast-growing CPG brand to deliver best-in-class ecommerce to its clientele, as well as increase sales, profits and conversion rates, and execute R&D upgrades in real-time ... About NoginNogin delivers Commerce as a Service to leading brands in the fashion, CPG, beauty, health, and wellness industries ... .
SCB-2019 (CpG 1018/Alum) demonstrated 100% efficacy against severe COVID-19 and hospitalizations and 84% efficacy against moderate-to-severe COVID-19 caused by any strain of SARS-CoV-2. SCB-2019 (CpG 1018/Alum) demonstrated 79% overall efficacy against COVID-19 of any severity caused by the globally dominant Delta variant.
COVID-19 VaccineDeveloped by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in GlobalPhase 2/3 Trial... compared to placebo The impressive results in efficacy and tolerability reflect the beneficial profile of CpG 1018 as a valuable vaccine ... About CpG 1018 Adjuvant.
CpG-STAT3 Antisense inhibitor (CpG-STAT3ASO) ...The new patent covers the compound and composition, including phosphorothioated oligodeoxynucleotide, and methods of use for CpG-STAT3ASO, Duet's CpG-STAT3 Antisense inhibitor ... The Duet Platform is comprised of three distinctive, complementary CpG-STAT3 inhibitors ... CpG-STAT3siRNA ... CpG-STAT3ASO.
ErickDickens is co-founder and CEO of Kadenwood, a CBD company. As CEO, he credits his training in CPG companies with shaping his ability to lead Kadenwood as an innovator in developing new CBD products and experiences. Below is his insight ... .